Assignee
BIOTHERYX INC
US·34 granted patents·16 pending applications·68 citations·filing 2012–2024
Top patents by PatentIndex Score
50 records- 0195US10144745B2Chimeric compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2017·Granted Dec 4, 2018·15 cites·18 claims
- 0295US10040804B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2017·Granted Aug 7, 2018·17 cites·30 claims
- 0392US10889593B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2019·Granted Jan 12, 2021·4 cites·27 claims
- 0492US10336771B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2018·Granted Jul 2, 2019·8 cites·24 claims
- 0589US10513515B2Ether compounds and uses thereofBIOTHERYX INC·Filed 2018·Granted Dec 24, 2019·4 cites·28 claims
- 0688US10406165B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2018·Granted Sep 10, 2019·6 cites·25 claims
- 0787US10669260B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2017·Granted Jun 2, 2020·3 cites·15 claims
- 0886US10905684B2Aminoamide compoundsBIOTHERYX INC·Filed 2019·Granted Feb 2, 2021·2 cites·29 claims
- 0983US11236105B2Bicyclic compounds and methods of useBIOTHERYX INC·Filed 2020·Granted Feb 1, 2022·1 cites·22 claims
- 1082US9822098B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2016·Granted Nov 21, 2017·3 cites·22 claims
- 1180US10570147B2Bicyclic compounds and methods of useBIOTHERYX INC·Filed 2018·Granted Feb 25, 2020·2 cites·30 claims
- 1278US10844039B2Substituted isoindolinonesBIOTHERYX INC·Filed 2019·Granted Nov 24, 2020·1 cites·36 claims
- 1374US11345714B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2021·Granted May 31, 2022·0 cites·32 claims
- 1474US9527815B2Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseasesBIOTHERYX INC·Filed 2015·Granted Dec 27, 2016·2 cites·32 claims
- 1568US2024368114A1Indazoles, pharmaceutical compositions, and therapeutic applicationsBIOTHERYX INC·Filed 2024·Application pending·0 cites
- 1667US2022298172A1Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 1766US2022153751A1Bifunctional compoundsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 1865US10927104B2Ether compounds and uses thereofBIOTHERYX INC·Filed 2019·Granted Feb 23, 2021·0 cites·26 claims
- 1964US11400084B2Aminoamide compoundsBIOTHERYX INC·Filed 2021·Granted Aug 2, 2022·0 cites·21 claims
- 2064US11352338B2Substituted isoindolinonesBIOTHERYX INC·Filed 2020·Granted Jun 7, 2022·0 cites·22 claims
- 2164US2022088025A1Fused thiophene compoundsBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 2264US2024190883A1Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2023·Application pending·0 cites
- 2363US12419962B2Quinazolines, pharmaceutical compositions, and therapeutic applicationsBIOTHERYX INC·Filed 2023·Granted Sep 23, 2025·0 cites·23 claims
- 2463US11191769B2Fused thiophene compoundsBIOTHERYX INC·Filed 2019·Granted Dec 7, 2021·0 cites·39 claims
- 2563US2025186434A1Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2023·Application pending·0 cites
- 2662US11236103B2Bifunctional compoundsBIOTHERYX INC·Filed 2019·Granted Feb 1, 2022·0 cites·33 claims
- 2762US10562917B2Chimeric compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2018·Granted Feb 18, 2020·0 cites·22 claims
- 2861US9546131B2Substituted biaryl alkyl amidesBIOTHERYX INC·Filed 2014·Granted Jan 17, 2017·0 cites·27 claims
- 2961US9273005B2Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseasesBIOTHERYX INC·Filed 2012·Granted Mar 1, 2016·0 cites·17 claims
- 3061US2019276474A1Chimeric compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2018·Application pending·0 cites
- 3159US11345712B2Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2020·Granted May 31, 2022·0 cites·51 claims
- 3259US2024368121A1Estrogen receptor degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 3359US2024207268A1Pyrazolylpyrimidines for treating malignant solid tumorBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 3458US8822527B2Substituted biaryl alkyl amidesBIOTHERYX INC·Filed 2012·Granted Sep 2, 2014·0 cites·38 claims
- 3557US10106491B2Substituted biaryl alkyl amidesBIOTHERYX INC·Filed 2016·Granted Oct 23, 2018·0 cites·17 claims
- 3656US10857155B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2019·Granted Dec 8, 2020·0 cites·9 claims
- 3756US2024124418A1Pde4 degraders, pharmaceutical compositions, and therapeutic applicationsBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 3856US2024190885A1Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 3955US2023047732A1Pyrazolylpyrimidines and use thereofBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 4054US12522612B2PDE4 inhibitors, pharmaceutical compositions, and therapeutic applicationsBIOTHERYX INC·Filed 2020·Granted Jan 13, 2026·0 cites·37 claims
- 4154US11433047B2Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseasesBIOTHERYX INC·Filed 2016·Granted Sep 6, 2022·0 cites·35 claims
- 4254US2024197888A1Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 4354US2024025863A1Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 4452US10654805B2Pyridinethiones, pharmaceutical compositions thereof, and their therapeutic use for treating a proliferative, inflammatory, neurodegenerative, or immune-mediated diseaseBIOTHERYX INC·Filed 2019·Granted May 19, 2020·0 cites·26 claims
- 4552US2015342942A1Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridoneBIOTHERYX INC·Filed 2015·Application pending·0 cites
- 4650US2023002371A1Ras protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2020·Application pending·0 cites
- 4747US10233153B2Pyridinethiones, pharmaceutical compositions thereof, and their therapeutic use for treating a proliferative, inflammatory, neurodegenerative, or immune-mediated diseaseBIOTHERYX INC·Filed 2017·Granted Mar 19, 2019·0 cites·27 claims
- 4845US10584133B2Thienopyrimidinone compoundsBIOTHERYX INC·Filed 2019·Granted Mar 10, 2020·0 cites·44 claims
- 4945US10045972B2Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseasesBIOTHERYX INC·Filed 2016·Granted Aug 14, 2018·0 cites·31 claims
- 5036US9926277B2Pyridone compounds, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseasesBIOTHERYX INC·Filed 2016·Granted Mar 27, 2018·0 cites·43 claims
Join the waitlist — get patent alerts
Get an alert when BIOTHERYX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →